Elanco develops, manufactures, and markets products for companion and food animals. The сompany provides products and knowledge services to improve animal health and food-animal production. It offers companion animal disease prevention products, such as parasiticide products; companion animal therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications; vaccines, nutritional enzymes, and animal-only antibiotics; and a range of food animal products used in ruminant and swine production.
Gross profit (Q1, 2020)
Gross profit margin (Q1, 2020), %
Net income (Q1, 2020)
Market capitalization (26-Jun-2020)
Closing stock price (26-Jun-2020)
|Company Name||Date||Deal Size|
|Aratana Therapeutics||April 26, 2019||$245 m|
|Janssen Animal Health BVBA||July 07, 2011|
Elanco has 13.53k Twitter Followers. The number of followers has increased 0.2% month over month and increased 2.2% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Elanco founded?
Elanco was founded in 1954.
Who are Elanco key executives?
Elanco's key executives are Jeffrey N. Simmons, Julie Lawless and Ramiro M. Cabral.
How many employees does Elanco have?
Elanco has 5,780 employees.
Who are Elanco competitors?
Competitors of Elanco include Zoetis, Merck Animal Health USA and Meditop Pharmaceutical.
Where is Elanco headquarters?
Elanco headquarters is located at 2500 Innovation Way, Greenfield.
Where are Elanco offices?
Elanco has offices in Greenfield, DNN, Melrose Park, Wien and in 28 other locations.
How many offices does Elanco have?
Elanco has 42 offices.
Receive alerts for 300+ data fields across thousands of companies